Cancel
Arvinder Dhalla
Vice President, Clinical Development
@
Rani Therapeutics
4g4gq2qw.z4218y@1f2x1f70819f6g6g.10x
Sign up to see email
Known information
- Joined InCube Labs in 2016.
- Has more than 15 years of experience in pharmaceutical research and development.
- Has experience in project management and regulatory submissions.
- Worked at Gilead Sciences from 2009-2015 as Director of Biology in the Cardiovascular Therapeutic Area.
- Led multiple drug development programs from early discovery to clinical development at Gilead Sciences.
- Worked as a scientist and senior scientist at CV Therapeutics from 2001-2008.
- Holds several patents.
- Authored 50 scientific papers.
- Holds a BS and MS in Biophysics from Panjab University, India.
- Earned a PhD in Physiology from the University of Manitoba, Canada.
About Rani Therapeutics
Rani Therapeutics has developed a disruptive technology for the oral delivery of biologics, aiming to replace painful injections with their innovative RaniPill platform.
Report inaccurate information
